After 30 years, scientists finally have a drug for a deadly brain disease
RegulatoryapprovedZanvastroPositive
AI Analysis
Summary
The FDA approved Zanvastro, the first drug to directly target Alexander disease, a rare neurological disorder. Clinical trials demonstrated the drug stabilized motor function and improved movement in some patients.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
FDA approved first drug directly targeting Alexander disease
Importance:9/10
Sentiment:
0.90
FDA approvalrare diseaseneurological disorderfirst-in-classclinical trial positive
Read the original article
Published by ScienceDaily Pharmaceuticals on October 13, 2026 12:43 AM